This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For patients discharged from the hospital with confirmed COVID-19, median five-month follow-up MRI findings revealed a greater likelihood of regional brain volume reduction, parenchymal lung abnormalities and loss of corticomedullary differentiation in the kidney in comparison to people who have not had COVID-19.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge. The Challenge aims to identify research that addresses ways prostate cancer treatments can be improved with the gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix in patients who rece
milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge. The Challenge aims to identify research that addresses ways prostate cancer treatments can be improved with the gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix in patients who rece
milla1cf Wed, 09/27/2023 - 15:08 September 27, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , announced presentations on POSLUMA (flotufolastat F 18) injection (formerly known as 18F-rhPSMA-7.3 ) at the upcoming American Society for Therapeutic Radiology and Oncology ( ASTRO ) 2023 Annual Meeting, to be held in San Diego, Calif., from October 1 to 4, 2023.
At its core, teleradiology is the electronic transmission of medical imaging studies, like X-rays, MRIs, and CT scans, from one location to another. This allows radiologists and doctors to evaluate, diagnose, and consult regardless of their physical distance from the imaging source. Utilizing advanced secure networks and specialized software, teleradiology ensures timely delivery and high-quality images, making healthcare more accessible and collaborative.
milla1cf Wed, 09/27/2023 - 14:56 September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer , a cancer type that’s typically resistant to immunotherapy alone.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Take Home Points: In the context of poisoning, a “wide QRS” is anything greater than 100 milliseconds. A newly “wide QRS”, especially with hemodynamic instability, should prompt consideration of sodium channel blockade and not ventricular tachycardia. Treatment is guided by administration of sodium-bicarbonate. Recall that the resultant alkalemia driven by sodium-bicarbonate will shift potassium intracellularly.
Thirty-five percent of the interventional radiology malpractice cases involved vascular procedures and 26 percent of overall malpractice cases that went to trial resulted in plaintiff judgments with the average award being over $2 million.
A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in the Journal of Nuclear Medicine. By providing whole-body quantification of HER2 expression, 68Ga-ABY-025 PET/CT can play a valuable role in treatment planning and could spare patients from unnecessary drug-related side effects.
Did you know that you can save time by using dictation within Purview Image™? Or edit a DICOM image for anonymization, to correct errors and so on? There are many use cases for Purview Image with a growing customer user base ranging from radiology to veterinary to research and education.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
In April 2023, the National Health Service (NHS) released data showing that nearly 40% of patients were waiting in the A&E departments beyond the 4-hour target mark, with 27,000 patients waiting up to 12 hours before seeing a physician. The problem is exacerbated by an ongoing shortage of radiologists, as the Royal College of Radiology estimates there is a 29% shortfall of radiologists to meet imaging demands, which will rise to an estimated 40% in five years without action.
New research indicates that a novel imaging agent, 68Ga-ABY-025, may help predict early metabolic responses to HER2-specific therapies in patients with HER2-positive metastatic breast cancer.
A new study has shown that human radiologists were generally more accurate than AI in identifying the presence and absence of common lung diseases on chest X-rays.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
A team at the University of Texas at Arlington will use a $450,000 grant to develop a predictive analytics tool to forecast which patients’ diseases will recur.
To assess the safety and effectiveness of the Rotarex S rotational mechanical atherothrombectomy device in patients with symptomatic Iliac limb occlusion following abdominal endovascular aneurysm repair (EVAR).
Publication date: Available online 26 September 2023 Source: Clinical Radiology Author(s): Benjamin Hawthorn, Bhavin Kawa, Thomas Cavenagh, Sofia Katsari, Rahul Lohan, Michael Gonsalves, Lakshmi Ratnam, Uday Patel, Robert Morgan
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
An AI chest X-ray foundation model for disease detection demonstrated racial and sex-related bias leading to uneven performance across patient subgroups and may be unsafe for clinical applications, according to a study published in Radiology: Artificial Intelligence. The study aims to highlight the potential risks for using foundation models in the development of medical imaging artificial intelligence.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content